Work

The Wisconsin HIV Drug Assistance Program: A Cost-Benefit Analysis

Year: 2025

Type: report

Abstract: In the Fall of 2025, as a part of Public Affairs 881: Cost-Benefit Analysis at the University of Wisconsin-Madison, a cost-benefit analysis was conducted for the Wisconsin Department of Health Services (DHS) on the state’s HIV Drug Assistance Program (HDAP). We publish our final report, non-confidential Affordable Care Act (ACA) plan data, analysis workbooks, code of our forecasting models, and code of our Monte Carlo Analysis. Forecasting models were built utilizing confidential HDAP client data that we are unable to publish because of HIPAA privacy protections and our Data Use Agreement with WI DHS.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.17850836

Authors: Austin, Travis, Chen, Mufan, McCormick, Hunter, Neumann, Brett, Pincombe, Morgan, Preisler, Jessica

Institution: University of Wisconsin–Madison

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7125010970

Cites:

Cited by:

Related to: